Long Shortz with Audeara: Record revenues and a bold FY26 outlook

Tylah Tully chats with Audeara (ASX:AUA) CEO Dr James Fielding after the company achieved record revenues for FY25 with a month still remaining in the financial year.

Fielding attributes the success to consistent Australian sales, expanding international licensing and white labelling opportunities.

He highlights the launch of Audeara Buds, a personal sound amplifier using Audeara’s core hearing technology, with plans to launch them as medical devices in China by year’s end.

Watch the video to learn more.

This video was developed in collaboration with Audeara, a Stockhead client at the time of publishing.

The interviews and discussions in this video are opinions only and not financial or investment advice. Viewers should obtain independent advice based on their own circumstances before making any financial decisions.